|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Cymabay Therapeutics, Inc. (CBAY) |
|
|
$32.48 0.00 (0.00%) as of 4:30 Thu 3/21
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
114,780,000 |
Market
Cap: |
3.73(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$7.47 - $32.48 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile CymaBay Therapeutics is a clinical-stage biopharmaceutical company focused on developing and providing access to therapies for patients with liver and other chronic diseases. Co.'s pipeline includes the following clinical stage product candidates: seladelpar, a selective agonist for the peroxisome proliferator-activated receptor delta, which is a nuclear receptor that regulates genes involved in bile acid/sterol, lipid, and glucose metabolism, and regulation of certain inflammatory cells; and MBX-2982, which targets G protein-coupled receptor 119 (GPR119), a receptor that interacts with bioactive lipids known to stimulate glucose-dependent insulin secretion.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
51,301 |
Total Buy Value |
$0 |
$0 |
$0 |
$100,037 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
1 |
Total Shares Sold |
0 |
154,097 |
525,762 |
672,611 |
Total Sell Value |
$0 |
$3,367,924 |
$8,694,896 |
$10,085,429 |
Total People Sold |
0 |
5 |
6 |
7 |
Total Sell Transactions |
0 |
10 |
31 |
36 |
End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Menold Daniel |
Vice President, Finance |
|
2018-08-29 |
4 |
OE |
$5.00 |
$25,000 |
D/D |
5,000 |
5,000 |
|
- |
|
Shah Sujal |
Chief Executive Officer |
|
2018-07-27 |
4 |
B |
$10.90 |
$54,500 |
D/D |
5,000 |
95,000 |
2.81 |
- |
|
Emster Kurt Von |
Director |
|
2018-06-05 |
4 |
S |
$12.51 |
$11,509 |
I/I |
(920) |
18,316 |
|
- |
|
Emster Kurt Von |
Director |
|
2018-06-05 |
4 |
OE |
$5.75 |
$11,500 |
I/I |
2,000 |
19,236 |
|
- |
|
Shah Sujal |
Chief Executive Officer |
|
2018-05-11 |
4 |
B |
$10.65 |
$53,250 |
D/D |
5,000 |
90,000 |
2.81 |
- |
|
Goldfischer Carl |
Director |
|
2018-03-22 |
4 |
S |
$13.03 |
$195,375 |
D/D |
(15,000) |
0 |
|
- |
|
Goldfischer Carl |
Director |
|
2018-03-22 |
4 |
OE |
$5.00 |
$77,830 |
D/D |
15,000 |
15,000 |
|
- |
|
Emster Kurt Von |
Director |
|
2018-03-05 |
4 |
AS |
$15.51 |
$207,105 |
I/I |
(13,353) |
273,417 |
|
- |
|
Emster Kurt Von |
Director |
|
2018-02-15 |
4 |
AS |
$14.49 |
$995,637 |
I/I |
(68,712) |
286,770 |
|
- |
|
Emster Kurt Von |
Director |
|
2018-02-14 |
4 |
AS |
$16.69 |
$2,720,120 |
I/I |
(162,979) |
355,482 |
|
- |
|
Emster Kurt Von |
Director |
|
2018-02-13 |
4 |
AS |
$13.51 |
$744,104 |
I/I |
(55,078) |
518,461 |
|
- |
|
Emster Kurt Von |
Director |
|
2018-02-07 |
4 |
AS |
$12.35 |
$503,423 |
I/I |
(40,763) |
419,693 |
|
- |
|
Emster Kurt Von |
Director |
|
2018-02-05 |
4 |
AS |
$12.14 |
$228,608 |
I/I |
(18,831) |
460,456 |
|
- |
|
Emster Kurt Von |
Director |
|
2018-02-02 |
4 |
AS |
$12.11 |
$24,220 |
I/I |
(2,000) |
479,287 |
|
- |
|
Emster Kurt Von |
Director |
|
2018-02-01 |
4 |
AS |
$12.15 |
$1,070,391 |
I/I |
(88,098) |
481,287 |
|
- |
|
Emster Kurt Von |
Director |
|
2018-01-31 |
4 |
AS |
$12.23 |
$150,429 |
I/I |
(12,300) |
569,385 |
|
- |
|
Emster Kurt Von |
Director |
|
2018-01-30 |
4 |
AS |
$12.22 |
$1,042,843 |
I/I |
(85,339) |
581,685 |
|
- |
|
Emster Kurt Von |
Director |
|
2018-01-25 |
4 |
AS |
$12.18 |
$480,355 |
I/I |
(39,438) |
667,024 |
|
- |
|
Emster Kurt Von |
Director |
|
2018-01-22 |
4 |
AS |
$10.40 |
$1,437,831 |
I/I |
(138,253) |
706,462 |
|
- |
|
Emster Kurt Von |
Director |
|
2018-01-19 |
4 |
AS |
$10.25 |
$1,338,486 |
I/I |
(130,584) |
844,715 |
|
- |
|
Emster Kurt Von |
Director |
|
2018-01-18 |
4 |
AS |
$10.21 |
$139,183 |
I/I |
(13,632) |
975,299 |
|
- |
|
Emster Kurt Von |
Director |
|
2018-01-05 |
4 |
AS |
$10.21 |
$43,903 |
I/I |
(4,300) |
988,931 |
|
- |
|
Emster Kurt Von |
Director |
|
2017-12-22 |
4 |
AS |
$9.41 |
$1,629,304 |
I/I |
(173,192) |
993,231 |
|
- |
|
Emster Kurt Von |
Director |
|
2017-11-10 |
4 |
AS |
$9.26 |
$463,379 |
I/I |
(50,048) |
1,166,423 |
|
- |
|
Mcwherter Charles |
SVP & Chief Scientific Officer |
|
2017-11-02 |
4 |
B |
$8.67 |
$43,341 |
D/D |
5,000 |
15,000 |
2.74 |
- |
|
156 Records found
|
|
Page 5 of 7 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|